Literature DB >> 25087120

Cellular FLICE-like inhibitory protein protects against cardiac hypertrophy by blocking ASK1/p38 signaling in mice.

Ying Huang1, Lianpin Wu, Jian Wu, Yumei Li, Lili Hou.   

Abstract

Cellular FLICE-like inhibitory protein (Flip) is a negative regulator of nuclear factor κB signaling which has been shown previously to complicate with cardiac hypertrophy. In the present study, we tested the hypothesis that the knockout of Flip would increase cardiac hypertrophy in vivo and in vitro. The effects of Flip knockout on cardiac hypertrophy were investigated using in vitro and in vivo models. Flip was downregulated in transverse aortic constriction (TAC)-induced animal hearts and cardiomyocytes that had been treated with angiotensin II or phenylephrine for 1 h. An in vivo, heart hypertrophy model, was performed by TAC in Flip knockdown and sham mice. The extent of hypertrophy of heart was quantitated by echocardiography, and further confirmed by pathological and molecular examination of heart tissue samples. Conditional knockout of Flip in the murine heart increases the hypertrophic response induced by TAC, whereas cardiac function was preserved with reduced Flip levels in response to hypertrophic stimuli. Western blot experiments further showed Flip knockout activated markedly ASK1/P38 signaling cascades in vivo and in vitro. In conclusion, Flip preserves cardiac functions and inhibits cardiac hypertrophy partially by blocking ASK1/P38 signaling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25087120     DOI: 10.1007/s11010-014-2175-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

1.  Cellular FLIP is expressed in cardiomyocytes and down-regulated in TUNEL-positive grafted cardiac tissues.

Authors:  T Imanishi; C E Murry; H Reinecke; T Hano; I Nishio; W C Liles; L Hofsta; K Kim; K D O'Brien; S M Schwartz; D K Han
Journal:  Cardiovasc Res       Date:  2000-10       Impact factor: 10.787

2.  NF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression.

Authors:  Feiyan Liu; Kankana Bardhan; Dafeng Yang; Muthusamy Thangaraju; Vadivel Ganapathy; Jennifer L Waller; Georgia B Liles; Jeffrey R Lee; Kebin Liu
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

3.  Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study.

Authors:  Christiane E Angermann; Stefan Störk; Götz Gelbrich; Hermann Faller; Roland Jahns; Stefan Frantz; Markus Loeffler; Georg Ertl
Journal:  Circ Heart Fail       Date:  2011-09-28       Impact factor: 8.790

4.  Fas/CD95-induced chemokines can serve as "find-me" signals for apoptotic cells.

Authors:  Sean P Cullen; Conor M Henry; Conor J Kearney; Susan E Logue; Maria Feoktistova; Graham A Tynan; Ed C Lavelle; Martin Leverkus; Seamus J Martin
Journal:  Mol Cell       Date:  2013-02-21       Impact factor: 17.970

5.  Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload.

Authors:  Cornel Badorff; Hartmut Ruetten; Sven Mueller; Meike Stahmer; Doris Gehring; Frank Jung; Christian Ihling; Andreas M Zeiher; Stefanie Dimmeler
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

6.  The cardiac Fas (APO-1/CD95) Receptor/Fas ligand system : relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes.

Authors:  K C Wollert; J Heineke; J Westermann; M Lüdde; B Fiedler; W Zierhut; D Laurent; M K Bauer; K Schulze-Osthoff; H Drexler
Journal:  Circulation       Date:  2000-03-14       Impact factor: 29.690

Review 7.  The ASK1-MAP kinase cascades in mammalian stress response.

Authors:  Jun Matsukawa; Atsushi Matsuzawa; Kohsuke Takeda; Hidenori Ichijo
Journal:  J Biochem       Date:  2004-09       Impact factor: 3.387

8.  p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload.

Authors:  Masanori Sano; Tohru Minamino; Haruhiro Toko; Hideyuki Miyauchi; Masayuki Orimo; Yingjie Qin; Hiroshi Akazawa; Kaoru Tateno; Yosuke Kayama; Mutsuo Harada; Ippei Shimizu; Takayuki Asahara; Hirofumi Hamada; Shuhei Tomita; Jeffrey D Molkentin; Yunzeng Zou; Issei Komuro
Journal:  Nature       Date:  2007-03-04       Impact factor: 49.962

9.  Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure.

Authors:  Yiwen Li; Genzou Takemura; Ken-ichiro Kosai; Tomoyuki Takahashi; Hideshi Okada; Shusaku Miyata; Kentaro Yuge; Satoshi Nagano; Masayasu Esaki; Ngin Cin Khai; Kazuko Goto; Atsushi Mikami; Rumi Maruyama; Shinya Minatoguchi; Takako Fujiwara; Hisayoshi Fujiwara
Journal:  Circ Res       Date:  2004-08-05       Impact factor: 17.367

10.  A non-specific effect associated with conditional transgene expression based on Cre-loxP strategy in mice.

Authors:  Linghua Qiu; Jaime A Rivera-Pérez; Zuoshang Xu
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

View more
  3 in total

1.  Cross-talk between Arg methylation and Ser phosphorylation modulates apoptosis signal-regulating kinase 1 activation in endothelial cells.

Authors:  Ming Chen; Xiaosheng Qu; Zhiqing Zhang; Huayu Wu; Xia Qin; Fuji Li; Zhenfang Liu; Liyuan Tian; Jianhua Miao; Wei Shu
Journal:  Mol Biol Cell       Date:  2016-02-24       Impact factor: 4.138

2.  Nephroprotective Effects of N-Acetylcysteine Amide against Contrast-Induced Nephropathy through Upregulating Thioredoxin-1, Inhibiting ASK1/p38MAPK Pathway, and Suppressing Oxidative Stress and Apoptosis in Rats.

Authors:  Xuezhong Gong; Yiru Duan; Junli Zheng; Yiquan Wang; Guohua Wang; Svante Norgren; Tom K Hei
Journal:  Oxid Med Cell Longev       Date:  2016-12-26       Impact factor: 6.543

3.  Interactions between the ERK1/2 signaling pathway and PCAF play a key role in PE‑induced cardiomyocyte hypertrophy.

Authors:  Qian Mao; Shuqi Wu; Chang Peng; Bohui Peng; Xiaomei Luo; Lixin Huang; Huanting Zhang
Journal:  Mol Med Rep       Date:  2021-07-19       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.